Inflammation, glucocorticoids and risk of cardiovascular disease

被引：0

作者：

Frank Buttgereit

Gerd-Rüdiger Burmester

Brian J Lipworth

机构：

[1] Charité University Medicine,F Buttgereit is Professor of Rheumatology and G

[2] Berlin,R Burmester is Professor of Medicine in the Department of Rheumatology and Clinical Immunology

[3] Germany.,BJ Lipworth is Professor of Allergy and Respiratory Medicine and Head of the Asthma and Allergy Research Group in the Department of Clinical Pharmacology and Therapeutics

[4] University of Dundee School of Medicine,undefined

[5] Dundee,undefined

[6] Scotland,undefined

[7] UK.,undefined

来源：

Nature Clinical Practice Rheumatology | 2009年 / 5卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A considerable increase in the risk of developing cardiovascular disease is conveyed not only by inflammation, but also by the use of glucocorticoids to treat inflammation. In this Viewpoint, the authors discuss the challenge of balancing the relative benefits and hazards of glucocorticoid treatment for inflammatory diseases, as well as the tantalizing prospect of identifying subgroups of the population at risk for cardiovascular disease.

引用

页码：18 / 19

页数：1

共 50 条

[31] Inflammation and Cardiovascular Disease Risk: A Case Study of HIV and Inflammatory Joint Disease
Rahman, Faisal
Martin, Seth S.
Whelton, Seamus P.
Mody, Freny V.
Vaishnav, Joban
McEvoy, John William
AMERICAN JOURNAL OF MEDICINE, 2018, 131 (04): : 442.e1 - 442.e8
[32] Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis
Tektonidou, Maria G.
JOURNAL OF AUTOIMMUNITY, 2022, 128
[33] Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?
Welsh, Paul
Grassia, Gianluca
Botha, Shani
Sattar, Naveed
Maffia, Pasquale
BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (22) : 3898 - 3913
[34] Inflammation, infection, and cardiovascular risk
Goldman, Michel
Bondue, Antoine
Cogan, Elie
LANCET, 2024, 403 (10431): : 1023 - 1023
[35] Chronic inflammation and cardiovascular risk
Ker, J. A.
SOUTH AFRICAN FAMILY PRACTICE, 2010, 52 (01) : 18 - 18
[36] Obesity, Inflammation, and Cardiovascular Risk
Mathieu, P.
Lemieux, I.
Despres, J-P
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (04) : 407 - 416
[37] Inflammation as a cardiovascular risk factor
Willerson, JT
Ridker, PM
CIRCULATION, 2004, 109 (21) : 2 - 10
[38] Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk
Vaccarezza, Mauro
Galassi, Francesco Maria
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
[39] Inflammation: A pathogenetic mechanism or a mediator, linking risk factors and cardiovascular disease?
Oikonomou, Evangelos
Tousoulis, Dimitris
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 264 : 170 - 171
[40] Exercise training reduces vascular inflammation in patients with cardiovascular risk or disease
Niessner, A
Richter, B
Penka, M
Steiner, S
Strasser, B
Ziegler, S
Heeb-Elze, E
Zorn, G
Leitner-Heinschink, A
Wojta, J
Huber, K
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 232A - 232A

← 1 2 3 4 5 →